trending Market Intelligence /marketintelligence/en/news-insights/trending/hbzx5xk-xkjpu02h2pxh1g2 content esgSubNav
In This List

QRxPharma adds director to board

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


QRxPharma adds director to board

QRxPharma Ltd. appointed Anthony Jefferies to its board.

Jefferies is a partner at Gillis Delaney Lawyers.

Australia's QRxPharma develops pain medications.